Last quarter (Q3 2023), Clearside Biomedical's total revenue was $859.00K, an increase of 222.93% from the same quarter last year. In Q3, Clearside Biomedical's net income was $-9.27M. See Clearside Biomedical’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 2.21M	$ 1.33M	$ 29.57M	$ 7.89M	$ 2.17M	$ 30.00K
Cost of Revenue	$ 355.00K	$ 204.00K	-	-	-	-
Gross Profit	$ 1.86M	$ 1.12M	$ 29.57M	-	-	-
Operating Expense	$ 15.20M	$ 31.60M	$ -30.20M	$ 25.83M	$ 32.48M	$ 82.97M
Operating Income	$ -30.00M	$ -30.28M	$ -627.00K	$ -17.93M	$ -30.30M	$ -82.94M
Net Non Operating Interest Income Expense	-	-	-	-	-	-
Other Income Expense	$ -511.00K	$ -669.00K	$ -1.00M	$ -275.00K	$ -466.00K	$ 127.00K
Pretax Income	$ -29.49M	$ -29.61M	$ 376.00K	$ -18.21M	$ -30.77M	$ -82.82M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -39.91M	$ -32.95M	$ 376.00K	$ -18.21M	$ -30.77M	$ -82.82M
Basic EPS	$ -0.87	$ -0.55	$ 0.01	$ -0.39	$ -0.81	$ -2.69
Diluted EPS	$ -0.61	$ -0.55	$ 0.01	$ -0.39	$ -0.81	$ -2.69
Basic Average Shares	$ 245.01M	$ 60.20M	$ 58.49M	$ 46.51M	$ 38.17M	$ 30.73M
Diluted Average Shares	$ 245.01M	$ 60.20M	$ 59.91M	$ 46.51M	$ 38.17M	$ 30.73M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 15.55M	$ 31.81M	$ -30.20M	$ 25.83M	$ 32.48M	$ 82.97M
Net Income From Continuing And Discontinued Operation	$ -39.91M	$ -32.95M	$ 376.00K	$ -18.21M	$ -30.77M	$ -82.82M
Normalized Income	$ -10.63M	-	-	$ -18.21M	$ -30.77M	$ -82.82M
Interest Expense	-	-	-	-	-	-
EBIT	$ -29.49M	$ -29.61M	$ 376.00K	$ -17.93M	$ -30.30M	$ -82.94M
EBITDA	$ -29.42M	$ -29.46M	$ 554.00K	$ -17.75M	$ -30.09M	$ -82.76M

Currency in USD

Clearside Biomedical Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing